Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans.

Slides:

Advertisements

Similar presentations

Diastolic Heart Failure, HFpEF, HFnEF: What are we treating anyway? Charles M. Rasmussen, MD FACC.

Advertisements

Fonarow GC, et al. J Am Coll Cardiol. 2007;50:768  777. Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized.

Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.

Yancy et al. J Am Coll Cardiol. 2008;51:1675  84. Quality of Care of and Outcomes for African Americans Hospitalized With Heart Failure: Findings From.

Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Randomized Trial to Assess Catheter Ablation Versus.

Date of download: 5/28/2016 From: New Fibrate Use and Acute Renal Outcomes in Elderly Adults: A Population-Based Study Ann Intern Med. 2012;156(8):

Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Renoprotective Effect of Renin-Angiotensin-Aldosterone.

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: TCTAP C-162 Unique Features of Spontaneously Recanalyzed.

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Path to an Angiotensin Receptor Antagonist-Neprilysin.

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: AACVPR/ACC/AHA 2007 Performance Measures on Cardiac.

Date of download: 5/30/2016 Copyright © The American College of Cardiology. All rights reserved. From: Peripheral Artery Disease: Evolving Role of Exercise,

Date of download: 5/30/2016 Copyright © The American College of Cardiology. All rights reserved. From: Disparities in Cardiac Care: Rising to the Challenge.

Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Cardiogenic and Aortogenic Brain Embolism J Am Coll.

Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Beta-Blockers and Outcome in Heart Failure and Atrial.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Survival of patients with diabetes and multivessel.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship Between Operator Volume and Adverse.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prognostic value of coronary artery calcium screening.

Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Treatment Times Through Formalized.

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Frequency and Practice-Level Variation in Inappropriate.

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Ventricular Tachyarrhythmias With Statins.

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. Benefit of Anticoagulation Unlikely in Patients With Atrial.

Date of download: 6/22/2016 Copyright © The American College of Cardiology. All rights reserved. From: Association of Guideline-Based Admission Treatments.

Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: Outcomes Associated With Microalbuminuria: Effect.

Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prognostic implications of atrial fibrillation in.

Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Irbesartan, an angiotensin type 1 receptor inhibitor,

Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Overview of the 2011 Food and Drug Administration.

Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Has Public Reporting of Hospital Readmission Rates.

Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Readmissions After Carotid Artery Revascularization.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Influence of Left Ventricular Ejection Fraction.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2014 AHA/ACC/HRS Guideline for the Management of.

Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.

Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Limitations of Ejection Fraction for Prediction.

Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Utility of B-type natriuretic peptide in the diagnosis.

Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: The metabolic syndrome, diabetes, and subclinicalatherosclerosis.

Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.

Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Sex Differences in Hospital Mortality in Adults With.

Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:

Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Ventricular Arrhythmia After Cardiac Surgery: Incidence,

Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Hypertrophic Cardiomyopathy in Adulthood Associated.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Association of cardiac troponin, CK-MB, and postoperative.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Tolerability and efficacy of carvedilol in patients.

Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Results of Low-Dose Human Atrial Natriuretic Peptide.

Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Healthy Lifestyle and Decreasing Risk of Heart Failure.

Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Spironolactone inhibits the transcardiac extraction.

Date of download: 7/11/2016 Copyright © The American College of Cardiology. All rights reserved. From: Movement of the Esophagus During Left Atrial Catheter.

From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.

Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/AHA 2011 Expert Consensus Document on Hypertension.

Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Angiotensin II type 1 receptor antagonist decreases.

Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship between tumor necrosis factor-alpha.

Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Evidence That D-Dimer Levels Predict Subsequent.

Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Presidential address: quality of cardiovascular.

Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: U.S. Hospital Use of Echocardiography: Insights.

Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Resting Heart Rate in Cardiovascular Disease J Am.

From: Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure: A Systematic Overview and Meta-Analysis.

From: Incidence, Predictive Factors, and Prognostic Value of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Implantation J Am Coll.

Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Asymptomatic Individuals With a Positive Family.

Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2016 ACC Expert Consensus Decision Pathway on the.

From: Genetic Inhibition of CETP, Ischemic Vascular Disease and Mortality, and Possible Adverse Effects J Am Coll Cardiol. 2012;60(20): doi: /j.jacc

Date of download: 11/13/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Reality of Heart Failure in Latin America J.

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,

Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;

Copyright © 2015 by the American Osteopathic Association.

J Am Coll Cardiol Img. 2012;5(11): doi: /j.jcmg Figure Legend:

Copyright © 2006 American Medical Association. All rights reserved.

Copyright © 2015 by the American Osteopathic Association.

Copyright © 2007 American Medical Association. All rights reserved.

Current and future paradigm for prognostication and testing of therapeutics in patients with heart failure using machine learning. Current and future paradigm.

Fig. 2. Evidence-based medication prescriptions

β-Blocker Use for the Stages of Heart Failure

Presentation transcript:

Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans Hospitalized With Heart Failure: Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry J Am Coll Cardiol. 2008;51(17): doi: /j.jacc Heart Failure Measures at Hospital Discharge Percent of patients who received heart failure measures at hospital discharge by race. ACE = angiotensin-converting enzyme; LVEF = left ventricular ejection fraction. Figure Legend:

Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans Hospitalized With Heart Failure: Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry J Am Coll Cardiol. 2008;51(17): doi: /j.jacc Other Medications at Hospital Discharge Eligible patients receiving other medications at hospital discharge by race. *ACE inhibitor and/or ARB use in patients with left ventricular systolic dysfunction (LVSD), excluding patients with contraindications to ACE inhibitor and/or ARB. †Beta-blocker use in patients with LVSD, excluding patients with contraindications to beta-blocker drugs. ‡Statin use in patients with medical history of coronary artery disease, cerebral vascular accident/transient ischemic attack, diabetes, hyperlipidemia, or peripheral vascular disease. §Aldosterone antagonist, hydralazine, and nitrate use in patients with LVSD. ∥ Warfarin use in patients with chronic or paroxysmal atrial fibrillation. ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker; HYDR/ISDN = hydralazine/isosorbide dinitrate. Figure Legend:

Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans Hospitalized With Heart Failure: Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry J Am Coll Cardiol. 2008;51(17): doi: /j.jacc Outcomes in Patients With Left Ventricular Systolic Dysfunction (A) In-hospital outcomes in heart failure patients with left ventricular systolic dysfunction (LVSD) by race. (B) The 60- to 90-day post- discharge outcomes in heart failure patients with LVSD by race. Figure Legend:

Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans Hospitalized With Heart Failure: Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry J Am Coll Cardiol. 2008;51(17): doi: /j.jacc Outcomes in Patients Without LVSD (A) In-hospital outcomes in heart failure patients without left ventricular systolic dysfunction (LVSD) by race. (B) The 60- to 90-day post-discharge outcomes in heart failure patients without LVSD by race. Figure Legend: